Charles Mcwherter - Net Worth and Insider Trading
Charles Mcwherter Net Worth
The estimated net worth of Charles Mcwherter is at least $567,300 dollars as of 2024-12-26. Charles Mcwherter is the President of R&D of CymaBay Therapeutics Inc and owns about 15,000 shares of CymaBay Therapeutics Inc (CBAY) stock worth over $487,200. Charles Mcwherter is also the Director of 89bio Inc and owns about 10,000 shares of 89bio Inc (ETNB) stock worth over $80,100. Details can be seen in Charles Mcwherter's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Charles Mcwherter has not made any transactions after 2024-12-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Charles Mcwherter
Charles Mcwherter Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Charles Mcwherter owns 1 companies in total, including CymaBay Therapeutics Inc (CBAY) .
Click here to see the complete history of Charles Mcwherter’s form 4 insider trades.
Insider Ownership Summary of Charles Mcwherter
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CBAY | CymaBay Therapeutics Inc | 2024-01-19 | Chief Scientific Officer |
Charles Mcwherter Latest Holdings Summary
Charles Mcwherter currently owns a total of 2 stocks. Among these stocks, Charles Mcwherter owns 15,000 shares of CymaBay Therapeutics Inc (CBAY) as of January 19, 2024, with a value of $487,200 and a weighting of 85.88%. Charles Mcwherter also owns 10,000 shares of 89bio Inc (ETNB) as of December 5, 2024, with a value of $80,100 and a weighting of 14.12%.
Latest Holdings of Charles Mcwherter
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CBAY | CymaBay Therapeutics Inc | 2024-01-19 | 15,000 | 32.48 | 487,200 |
| ETNB | 89bio Inc | 2024-12-05 | 10,000 | 8.01 | 80,100 |
Holding Weightings of Charles Mcwherter
Charles Mcwherter Form 4 Trading Tracker
According to the SEC Form 4 filings, Charles Mcwherter has made a total of 9 transactions in CymaBay Therapeutics Inc (CBAY) over the past 5 years, including 0 buys and 9 sells. The most-recent trade in CymaBay Therapeutics Inc is the sale of 18,403 shares on January 19, 2024, which brought Charles Mcwherter around $435,599.
According to the SEC Form 4 filings, Charles Mcwherter has made a total of 1 transactions in 89bio Inc (ETNB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in 89bio Inc is the acquisition of 10,000 shares on December 5, 2024, which cost Charles Mcwherter around $80,000.
Insider Trading History of Charles Mcwherter
- 1
Charles Mcwherter Trading Performance
GuruFocus tracks the stock performance after each of Charles Mcwherter's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Charles Mcwherter is 9.2%. GuruFocus also compares Charles Mcwherter's trading performance to market benchmark return within the same time period. The performance of stocks bought by Charles Mcwherter within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Charles Mcwherter's insider trading performs compared to the benchmark.
Performance of Charles Mcwherter
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.09 | | | | | |
| Relative Return to S&P 500(%) | 5.83 | | | | | |
Charles Mcwherter Ownership Network
Charles Mcwherter Owned Company Details
What does CymaBay Therapeutics Inc do?
Who are the key executives at CymaBay Therapeutics Inc?
Charles Mcwherter is the Chief Scientific Officer of CymaBay Therapeutics Inc. Other key executives at CymaBay Therapeutics Inc include Vice President & Finance Daniel Menold , General Counsel Paul T Quinlan , and director & Chief Executive Officer Sujal Shah .
CymaBay Therapeutics Inc (CBAY) Insider Trades Summary
Over the past 18 months, Charles Mcwherter made 7 insider transaction in CymaBay Therapeutics Inc (CBAY) with a net sale of 128,061. Other recent insider transactions involving CymaBay Therapeutics Inc (CBAY) include a net sale of 88,000 shares made by Paul T Quinlan , a net sale of 52,442 shares made by Daniel Menold , and a net sale of 19,000 shares made by Janet Dorling .
In summary, during the past 3 months, insiders sold 0 shares of CymaBay Therapeutics Inc (CBAY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 433,148 shares of CymaBay Therapeutics Inc (CBAY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 433,148 shares.
CymaBay Therapeutics Inc (CBAY)'s detailed insider trading history can be found in Insider Trading Tracker table.
CymaBay Therapeutics Inc Insider Transactions
Charles Mcwherter Mailing Address
Above is the net worth, insider trading, and ownership report for Charles Mcwherter. You might contact Charles Mcwherter via mailing address: C/o Cymabay Therapeutics, Inc., 7575 Gateway Blvd., Suite 110, Newark Ca 94560.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
